CWAM
Columbia Wanger Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $30.6M | Buy |
10,772,111
+5,574,453
| +107% | +$15.8M | 0.46% | 100 |
|
|
2017
Q3 | $14.9M | Sell |
5,197,658
-3,328,961
| -39% | -$9.52M | 0.22% | 152 |
|
|
2017
Q2 | $21.1M | Buy |
8,526,619
+2,507,029
| +42% | +$6.19M | 0.3% | 136 |
|
|
2017
Q1 | $21.7M | Sell |
6,019,590
-176,265
| -3% | -$636K | 0.31% | 140 |
|
|
2016
Q4 | $21.9M | Buy |
6,195,855
+3,288,332
| +113% | +$11.6M | 0.31% | 141 |
|
|
2016
Q3 | $11.7M | Sell |
2,907,523
-2,354,411
| -45% | -$9.51M | 0.15% | 174 |
|
|
2016
Q2 | $23.1M | Buy |
5,261,934
+2,285,534
| +77% | +$10M | 0.27% | 139 |
|
|
2016
Q1 | $11.3M | Sell |
2,976,400
-633,608
| -18% | -$2.4M | 0.12% | 169 |
|
|
2015
Q4 | $56.6M | Buy |
3,610,008
+500,393
| +16% | +$7.85M | 0.57% | 67 |
|
|
2015
Q3 | $32.8M | Buy |
3,109,615
+517,912
| +20% | +$5.46M | 0.26% | 138 |
|
|
2015
Q2 | $65.4M | Sell |
2,591,703
-208,997
| -7% | -$5.27M | 0.42% | 91 |
|
|
2015
Q1 | $78.1M | Sell |
2,800,700
-396,000
| -12% | -$11M | 0.42% | 87 |
|
|
2014
Q4 | $58.3M | Sell |
3,196,700
-374,900
| -10% | -$6.84M | 0.29% | 115 |
|
|
2014
Q3 | $46.3M | Sell |
3,571,600
-12,000
| -0.3% | -$156K | 0.21% | 157 |
|
|
2014
Q2 | $58.5M | Buy |
3,583,600
+911,600
| +34% | +$14.9M | 0.23% | 145 |
|
|
2014
Q1 | $47.2M | Buy |
2,672,000
+1,001,000
| +60% | +$17.7M | 0.19% | 179 |
|
|
2013
Q4 | $40.5M | Buy |
+1,671,000
| New | +$40.5M | 0.15% | 199 |
|